Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive and more susceptible to developing cirrhosis and hepatocellular carcinoma. Currently, lifestyle interventions are the most essent...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaohan, Poulsen, Kyle L., Wu, Lijuan, Liu, Shan, Miyata, Tatsunori, Song, Qiaoling, Wei, Qingda, Zhao, Chenyang, Lin, Chunhua, Yang, Jinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376100/
https://www.ncbi.nlm.nih.gov/pubmed/35963848
http://dx.doi.org/10.1038/s41392-022-01119-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376100/
https://www.ncbi.nlm.nih.gov/pubmed/35963848
http://dx.doi.org/10.1038/s41392-022-01119-3

Ejemplares similares